The Guardian view on de-extinction: Jurassic Park may be becoming reality
By Editorial,
The Guardian
| 08. 19. 2022
We should be keeping endangered species alive rather than bringing animals back from extinction
"tasmanian tiger" by nicolas.boullosa is licensed under CC BY 2.0.
The last official sighting of a Tasmanian tiger in the wild occurred in 1930, when it was shot by a farmer. The marsupials, formally known as thylacines, were hunted to extinction by European settlers who considered them a threat to their sheep and poultry. However, the 6ft-long creatures may reappear if a group of biotechnologists have their way.
The company Colossal Biosciences, along with researchers from the University of Melbourne, plans to “de-extinct” the thylacine by using gene-editing technology. Australia has the fastest rate of mammal extinction in the world; disappearances are down to the arrival of foreign species and wildfires linked to the climate crisis. Scientists argue that in Tasmania the loss of the thylacine left the numbers of smaller marsupials unchecked, leading to over-grazing and threatening a fragile ecological balance.
If it all sounds like a plot line from Jurassic Park, then that is because the science behind the resurrection plan provided the movie’s inspiration. Last year Colossal, co-founded by a Harvard geneticist, raised...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...